Skip to main content

Published locations for Adding polatuzumab extends survival in relapsed/refractory DLBCL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Adding polatuzumab extends survival in relapsed/refractory DLBCL

User login

  • Reset your password
  • /content/adding-polatuzumab-extends-survival-relapsed/refractory-dlbcl
  • /hematologynews/article/212445/b-cell-lymphoma/adding-polatuzumab-extends-survival-relapsed
  • /oncologypractice/article/212445/b-cell-lymphoma/adding-polatuzumab-extends-survival-relapsed
  • /hematology-oncology/article/212445/b-cell-lymphoma/adding-polatuzumab-extends-survival-relapsed
  • /b-cell-lymphoma-icymi/article/212445/b-cell-lymphoma/adding-polatuzumab-extends-survival-relapsed